Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
143.94
-4.36 (-2.94%)
At close: Mar 28, 2025, 4:00 PM
142.38
-1.56 (-1.09%)
After-hours: Mar 28, 2025, 7:59 PM EDT
Natera Market Cap
Natera has a market cap or net worth of $19.46 billion as of March 28, 2025. Its market cap has increased by 77.45% in one year.
Market Cap
19.46B
Enterprise Value
18.62B
1-Year Change
77.45%
Ranking
Category
Stock Price
$143.94
Market Cap Chart
Since July 2, 2015, Natera's market cap has increased from $1.10B to $19.46B, an increase of 1,667.04%. That is a compound annual growth rate of 34.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2025 | 20.05B | -4.07% |
| Dec 31, 2024 | 20.90B | 177.68% |
| Dec 29, 2023 | 7.53B | 91.96% |
| Dec 30, 2022 | 3.92B | -55.62% |
| Dec 31, 2021 | 8.83B | 3.98% |
| Dec 31, 2020 | 8.50B | 225.28% |
| Dec 31, 2019 | 2.61B | 202.62% |
| Dec 31, 2018 | 863.10M | 78.55% |
| Dec 29, 2017 | 483.40M | -21.19% |
| Dec 30, 2016 | 613.40M | 13.59% |
| Dec 31, 2015 | 540.00M | -50.96% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |